Citigroup’s QIAGEN NV QGENF Stock Holding History

Citigroup’s Portfolio QGENF Stock Details QGENF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-2,000	Closed	-$45K	–	7982
2016 Q1	$45K	Buy	+2,000	New	+$45K	﹤0.01%	6171
2014 Q4	–	Sell	-12,000	Closed	-$273K	–	7712
2014 Q3	$273K	Buy	+12,000	New	+$273K	﹤0.01%	4008
2013 Q3	–	Sell	-41,000	Closed	-$816K	–	7339
2013 Q2	$816K	Buy	+41,000	New	+$816K	﹤0.01%	3065

Other funds holding QGENF

BJCM

Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

GAM

Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return

Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Citigroup's QGENF Position: Q1 2017 in Review

Citigroup sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 159,431 shares — an estimated $4.47M sold.

Citigroup first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $12.5M in Q1 2015. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

Citigroup reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
Citigroup sold 159,431 QIAGEN NV shares in Q1 2017, an estimated $4.47M.
Citigroup first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
Citigroup's QIAGEN NV position peaked at $12.5M in Q1 2015.
6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.